Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT02179086 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02179086
- Sponsor
- NRG Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-04
- Primary completion
- 2025-07-07
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.